Pharmaceutical PV DIV - FSB
Ended Awarded
- Contract number
- SPE2DX26FFQPV
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $4,782
Award facts
- Contract value 100% obligated
- $4,782.33 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $4,782.33 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This firm fixed-price delivery order, issued on November 10, 2025, with an ultimate completion date of November 14, 2025, represents one of numerous orders placed under DMS Pharmaceutical Group's recently awarded Indefinite Delivery Contract (SPE2DR) within the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The delivery order carries no set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement.
DMS Pharmaceutical Group serves as a regional prime vendor under the broader $30.3 billion PPV-G GEN V acquisition strategy, authorized to supply a comprehensive range of pharmaceutical products including branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, and medical consumables to support Department of Defense healthcare operations globally. The underlying IDC, valued at $499,999,999 with a completion date of December 31, 2036, comprises a 30-month base period and three 30-month option periods, positioning the company as a critical supplier within the federal military medical supply chain. The contractor's extensive product portfolio spans oncology treatments, immunosuppressants, emergency medications, specialty surgical products, and routine pharmaceuticals, enabling it to fulfill the diverse and specialized requirements of military healthcare facilities worldwide.
Quick answers
Who was awarded contract SPE2DX26FFQPV?
SPE2DX26FFQPV was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on November 10, 2025.
How much is contract SPE2DX26FFQPV worth?
The government has obligated $4,782 on SPE2DX26FFQPV.
Is contract SPE2DX26FFQPV an order under another contract?
Yes. SPE2DX26FFQPV is a delivery order under SPE2DX17D9419, an indefinite delivery contract.
Was contract SPE2DX26FFQPV competed?
The extent of competition for SPE2DX26FFQPV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award